VivoSim Labs announced a $4.0 million private placement of pre-funded and common warrants, alongside related agreements to support and align the transaction. The Securities Purchase Agreement provides pre-funded warrants for 4,705,883 shares at a $0.001 exercise price and common warrants for 4,705,883 shares at a $0.85 exercise price, with proceeds for working capital and general corporate purposes. The company engaged A.G.P./Alliance Global Partners as placement agent for a 6.5% cash fee on gross proceeds. Separately, VivoSim Labs amended legacy Armistice warrants, resetting the exercise price to $0.85 and setting a five-year term after stockholder approval.
Agreement 1: VivoSim Labs Prices $4.0 Million Private Placement of Pre-Funded and Common Warrants
- Agreement type: Securities Purchase Agreement for $4.0 million private placement of pre-funded and common warrants
- Counterparty: Accredited Institutional Investor
- Signed / Effective: Jul 16 2026 / same
- Duration / Termination: N/A
- Reason: Bolster working capital and general corporate purposes
Agreement 2: VivoSim Labs Engages A.G.P./Alliance Global Partners as Placement Agent for $4.0 Million Offering
- Agreement type: Placement agency agreement for private placement
- Counterparty: A.G.P./Alliance Global Partners
- Signed / Effective: Jul 16 2026 / same
- Duration / Termination: N/A
- Reason: Facilitate execution of private placement
Agreement 3: VivoSim Labs Amends Armistice Warrants; Resets Price to $0.85, Five-Year Term Post Approval
- Agreement type: Amendment to Common Stock Purchase Warrants
- Counterparty: Armistice Capital Master Fund
- Signed / Effective: Jul 16 2026 / same
- Duration / Termination: 5 years after stockholder approval
- Reason: Align legacy warrants with new financing terms
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.